Session » Antiphospholipid Syndrome
-
Abstract Number: 1724
Pandemic Influenza Immunization in Primary Antiphospholipid Syndrome (PAPS): A Trigger to Autoantibody Production?
-
Abstract Number: 1725
ANTI-Factor Xa Antibodies ARE Significantly Increased in Patients with Systemic LUPUS Erythematosus and Antiphospholipid Syndrome
-
Abstract Number: 1726
Lack of Correlation Between Mannose-Binding Lectin Gene Polymorphisms and the Thickness of the Carotid Artery Intima-Media (IMT) in Primary Antiphspholipid Syndrome
-
Abstract Number: 1727
Affinity Purified Antibodies Directed to Domain I of β2GPI Are Pathogenic in a Mouse Model of Thrombosis
-
Abstract Number: 1728
Purified IgG From Antiphospholipid Syndrome Patients with Pregnancy Morbidity Alone Inhibit Trophoblast Migration and Activate a TLR4 MyD88 Independent Pathway
-
Abstract Number: 1729
Ribophorin II Is Involved in the Tissue Factor Expression Mediated by Phosphatidylserine-Dependent Antiprothrombin Antibody On Monocytes
-
Abstract Number: 1730
Antiphosphatidylethanolamine Is Not Associated with Thrombosis or Pregnancy Loss in Systemic Lupus Erythematosus
-
Abstract Number: 1731
IgA Anti-β2glycoprotein I Antibodies Are Pathogenic in a Mouse Model of APS
-
Abstract Number: 1732
Annexin A5 Resistance Identifies a Subset of Thrombosis Patients in Systemic Lupus Erythematosus
-
Abstract Number: 1733
Effect of Hydroxychloroquine (HCQ) On the Annexin A5 Resistance Assay (AnxA5-RA) in Antiphospholipid Antibody (aPL)-Positive Patients: Preliminary Results of an Ongoing Prospective Study
-
Abstract Number: 1734
Clinical Accuracy for Diagnosis of Antiphospholipid Syndrome in Systemic Lupus Erythematosus: Evaluation of 23 Possible Combinations of Antiphospholipid Antibody Specificities
-
Abstract Number: 1735
Independent Validation of the Antiphospholipid Score (aPL-S) for the Diagnosis of Antiphospholipid Syndrome (APS)
-
Abstract Number: 1736
The Estimated Prevalence of Antiphospholipid Antibodies in the General Population with Pregnancy Morbidity
-
Abstract Number: 1737
Diffuse Alveolar Hemorrhage Caused by Primary Antiphospholipid Syndrome
-
Abstract Number: 1738
Myocardial Dysfunction and Valvulopathy Worsens with Time in Patients with Antiphospholipid Syndrome: A 10-Year Follow-up Study
-
Abstract Number: 1740
Impairment of Quality of Life in Patients with Antiphospholipid Syndrome
-
Abstract Number: 2455
Establishment of Standardized International Units for IgG Anti-β2glycoprotein Antibody Measurement
-
Abstract Number: 2456
Pro-Inflammatory and Pro-Thrombotic Markers in Persistently Antiphospholipid Antibody-Positive Patients with/without Systemic Lupus Erythematosus
-
Abstract Number: 2457
An Open-Label Prospective Pilot Mechanistic Study of Fluvastatin in Persistently Antiphospholipid Antibody-Positive Patients
-
Abstract Number: 2458
The Estimated Prevalence of Antiphospholipid Antibodies in General Population Patients with Pregnancy Loss, Stroke, Myocardial Infarction, and Deep Vein Thrombosis